Archive (english)

This is a translation of the table of contents. One article of each issue is translated and freely available.

table of contents

SPOT ON

Oseltamivir (TAMIFLU): benefit of the neuraminidase inhibitor remains unclear

NEW ON THE MARKET

Dexamfetamine (ATTENTIN) for attention deficit hyperactivity disorder?

Azilsartan (EDABRI) - angiotensin II receptor blocker no. 8

a-t READER'S QUESTIONS AND COMMENTS

Perioperative management of patients with coronary heart disease taking acetylsalicylic acid

Does anticoagulation for atrial fibrillation protect against myocardial infarction?

Do sulfonylureas increase mortality?

What´s new on SINUPRET?

IN BRIEF

Placebo refused - how independent research is thwarted

CURRENT ADR NETWORK REPORT

Cancer due to liraglutide (VICTOZA)?
free

SIDE EFFECTS

Update: progressive leukoencephalopathy due to natalizumab (TYSABRI)

Consequences of deaths with multiple sclerosis drug fingolimod (GILENYA)

Independent drug information – in English

Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

Browse free articles